GlassScriptPhysician profile
Amy L Moon
NPI 1477520427
$11,751.70
in general payments reported to CMS, 2019-2025
49 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $2,129 · 2021: $1,887 · 2022: $1,854 · 2023: $1,432 · 2024: $2,456 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,349 · Travel and Lodging: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,349.21 |
| Travel and Lodging | $845.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,022.26 | 2019-2025 | |
| Novo Nordisk INC | $1,482.07 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Dysis Medical, INC. | $1,217.73 | 2019-2020 | |
| Applied Medical Resources Corporation | $885.98 | 2024 | Gelpoint V-Path |
| Hologic Sales and Service, LLC | $615.13 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $509.00 | 2020-2025 | Veozah |
| Sumitomo Pharma America, INC. | $496.08 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $461.64 | 2019-2022 | |
| Pfizer INC. | $419.06 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $346.93 | 2021-2025 | |
| Gynesonics, INC. | $346.32 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $246.48 | 2019-2025 | Slynd |
| Myovant Sciences INC. | $237.94 | 2021-2022 | |
| Lilly USA, LLC | $222.74 | 2022-2025 | Zepbound, Mounjaro, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $211.01 | 2019-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.